Introduction
LeuO is a LysR-type transcription regulator that is conserved in Proteobacteria (Henikoff et al., 1988) . LeuO is important in control of pathogenicity in Salmonella enterica, biofilm formation by Vibrio cholerae and Escherichia coli, control of the acid stress response and multidrug efflux in E. coli, and activation of the CRISPR-Cas immunity system in E. coli and S. enterica (HernandezLucas et al., 2008; Shimada et al., 2011; Hern andez-Lucas and Calva, 2012) . There is a significant overlap of LeuO target genes and loci that are repressed by the global regulator H-NS (heat-stable nucleoid structuring protein) in E. coli and S. enterica, and it is therefore presumed that LeuO works generally as an antagonist of H-NS (Shimada et al., 2011; Hern andez-Lucas and Calva, 2012; Dillon et al., 2012; Ishihama et al., 2016) .
Expression of leuO in E. coli and S. enterica is repressed by H-NS and its paralogue StpA, and leuO is therefore silent under standard laboratory growth conditions (Klauck et al., 1997; Chen et al., 2001) , while upon amino acid starvation and in stationary growth phase leuO expression is moderately upregulated (Fang et al., 2000; Majumder et al., 2001; Shimada et al., 2011; Dillon et al., 2012) . Further, in E. coli the heterodimeric BglJ-RcsB transcription regulator activates leuO . BglJ-RcsB is a heterodimer of the FixJ/NarL-type transcription factors BglJ, a response regulator-like protein, and RcsB, the response regulator of the Rcs (regulation of capsule synthesis) twocomponent phosphorelay (Giel et al., 1996; Majdalani and Gottesman, 2005) . In addition, positive autoregulation of leuO was reported (Fang et al., 2000) , but LeuO seems to work predominantly as an autorepressor, since it represses leuO transcription in hns stpA mutants and also counteracts activation by BglJ-RcsB Breddermann and Schnetz, 2016) . Transcription of leuO is presumably directed by several promoters. Promoter leuOp1 is active in hns stpA mutants, whereas promoter leuOp2 is activated by BglJ-RcsB . A further promoter, leuOp, is activated during growth arrest caused by branched-chain amino acid starvation (Chen et al., 2005) .
Here we show that LrhA, likewise a LysR-type transcription regulator, activates leuO transcription. LrhA is of pleiotropic function in E. coli, where it represses flhDC encoding the motility master regulator and expression of type 1 fimbriae genes, and is involved in the control of rpoS translation (Lehnen et al., 2002; Blumer et al., 2005; Peterson et al., 2006; Lee and Park, 2013) . In EHEC (enterohemorrhagic E. coli) LrhA activates genes pchA and pchB that encode activators of LEE (locus of enterocyte effacement) (Honda et al., 2009) . In Yersinia species the LrhA homologue, which is named RovM, activates biofilm formation and represses transcription of rovA encoding a key regulator of virulence gene expression (Heroven and Dersch, 2006; Liu et al., 2016) . LrhA homologues in Photorhabdus and Erwinia named HexA and PecT, respectively, repress virulence and control exopolysaccharide synthesis (Harris et al., 1998; Condemine et al., 1999; Mukherjee et al., 2000; Joyce and Clarke, 2003) . Taken together, LrhA apparently is a pleiotropic regulator in Enterobacteria and it is conserved in Proteobacteria.
LysR-type transcription regulators, like LeuO and LrhA, are characterized by an N-terminal winged helixturn-helix (wHTH) DNA-binding domain and a Cterminal effector-binding domain (Henikoff et al., 1988; Maddocks and Oyston, 2008) . In general, LysR-type regulators are tetramers that are formed by dimers of dimers. In these tetramers each subunit interacts with two different adjacent subunits. One dimerization interface is part of the N-terminal wHTH DNA-binding domain and important for building the dimer of DNAbinding domains, while the second dimerization interface maps to the C-terminal effector binding domains (Momany and Neidle, 2012) . Consequently, LysR-type transcription regulators contain two dimers of DNAbinding domains and thus two DNA contact sites. The steric arrangement of the two distinct dimeric DNAbinding domains can be affected by effector binding to the C-terminal domain (Jo et al., 2015; Lerche et al., 2016) . A further feature of LysR-type regulators is that they bind specifically to AT-rich DNA sequence motifs of the degenerate consensus T-N 11 -A. Specific binding to a rather degenerate DNA motif corresponds to the pleiotropic function of some LysR-type regulators such as LrhA, which is addressed in this work.
Here we isolated LrhA in a screen of a plasmid-based genomic library for activation of leuO transcription. Mapping of the LrhA DNA-binding region at leuO suggests an overlap with the LeuO DNA-binding sites and the presumptive H-NS nucleation site, and characterization of the transcription start sites suggests that LrhA activates leuO promoters leuOp1, leuOp, and a newly characterized transcription start site, leuOp3. In addition, co-regulation of leuO by LrhA with BglJ-RcsB, LeuO, and H-NS/StpA was analyzed. Further, we isolated LrhA mutants that have increased activity. One of these mutations mapping in the N-terminal DNA-binding domain enhances DNA binding, while other mutations map in the C-terminal effector binding domain. Expression of two of these mutants is deleterious to bacterial growth, underlining the pleiotropic function of LrhA.
Results

Identification of LrhA as positive regulator of leuO transcription
To identify factors that activate leuO expression we screened a genomic library of E. coli K-12 (Fig. 1 ). This library carries 1.5-5 kb genomic fragments cloned downstream of the IPTG-inducible P tac promoter in low-to-medium copy plasmid pKESK22 (p15A origin of replication) (Stratmann, 2012) . For the screen P leuO lacZ reporter strain T28 was used, which was transformed with the genomic library by electroporation and a total of approximately 150,000 single colonies were screened for Lac 1 phenotype on tryptone agar plates supplemented with X-Gal, IPTG and kanamycin (Fig. 1 ). In this screen 58 Lac 1 colonies were isolated which retained a Lac 1 phenotype when re-streaked. From 43 of these clones PCR products encompassing the genomic fragment could be amplified and were sequenced. Sequencing revealed that the clones represent 7 different loci. For each locus plasmid DNA of one representative was purified. Retransformation of P leuO lacZ reporter strain T28 with the plasmids revealed that 4 of the clones conferred a Lac 1 phenotype (Fig. 1) , while the other 3 clones, which were each isolated only once, did not confer a Lac 1 phenotype. The 4 plasmids that conferred a Lac 1 phenotype all carry genes coding for transcription regulators. These include bglJ (25 clones, 2 different fragments), cynR (7 clones, 4 different fragments), lrhA (one clone) and ydcI (7 clones, 3 different fragments). BglJ is a known activator of leuO transcription . Further, subclones of cynR, lrhA and ydcI in vector pKESK22 (lacI q P tac ) conferred a Lac 1 phenotype of P leuO lacZ reporter strain as well (Fig. 1) .
To quantify transcription activation of leuO by CynR, LrhA and YdcI the P leuO lacZ reporter strain T32 was activators of leuO was performed using a plasmid-based genomic library that carries genomic fragments inserted downstream of the P tac promoter in plasmid pKESK22 (p15A-ori) (Stratmann, 2012) . A total of 150,000 transformants of P leuO lacZ reporter strain T28 were screened for Lac 1 phenotypes on tryptone X-Gal IPTG kanamycin plates. Of 43 Lac 1 clones PCR fragments could be amplified by PCR with primers that flank the cloning site of the genomic fragments. Sequencing revealed that the clones represent 7 different loci which include genes bglJ (25 clones, 2 different fragments), cynR (7 clones, 4 different fragments), lrhA (one clone) and ydcI (7 clones, 3 different fragments) as well as three additional loci that were each isolated once. Re-transformation of plasmids representing the 7 different loci confirmed activation of P leuO lacZ by the bglJ, cynR, lrhA and ydcI clones, which all encode transcription regulators, but not by the other 3 clones. Transformants of P leuO lacZ reporter strain with subclones of bglJ (pKETS1), cynR (pKETS23), lrhA (pKEHB7) and ydcI (pKEHB6) were Lac 1 on tryptone X-Gal IPTG kanamycin as well.
used, a derivative of P leuO lacZ reporter strain T28 carrying a yjjQ-bglJ deletion (Fig. 2) . Cultures of transformants of this strain with cynR, lrhA, ydcI and bglJ expression plasmids were induced with 1 mM IPTG, and b-galactosidase activity was determined (Fig. 2) . In presence of LrhA the leuO promoter was activated 12-fold in comparison to the control (Fig. 2) . In presence of CynR and YdcI expression increased 5-and 6-fold respectively (Fig. 2) . In comparison, activation of the leuO promoter by BglJ-RcsB was 125-fold ( Fig. 2) , as shown before . For further analysis of the presumptive novel transcription activators of leuO we chose LrhA, which had the strongest effect. To analyze activation of leuO transcription by LrhA in the native genome context relative leuO expression was determined by qRT-PCR in absence and presence of LrhA (Fig. 2) . Expression of leuO was low in the lrhA 1 strain U3 and its isogenic DlrhA derivative (strain U79). When LrhA was provided from plasmid pKEHB7, expression increased 11-fold (Fig. 2) . In comparison, expression of bglJ caused a more than 60-fold activation (Fig. 2) , as demonstrated before . Taken together these results suggest that LrhA activates leuO transcription when provided from a plasmid, while deletion of the lrhA gene has no effect on leuO expression.
LrhA binds to leuO promoter region Next, binding of purified LrhA His6 protein to the leuO promoter region was analyzed in vitro using tiling DNA fragments spanning the 770 bp intergenic region between the leuO gene and the divergent leu operon (Fig. 3A) . In a first set of EMSA leuO DNA fragments I to V were mixed with a 262 bp lacZ control fragment and incubated with increasing concentrations of LrhA His6 (Fig. 3B) . Bands of the leuO fragment and the control fragment were apparent when no LrhA was added (Fig.  3B ). For leuO fragment "IV" the band of the leuO fragment vanished as of a concentration of 250 nM LrhA, while the control fragment remained unaffected, suggesting binding of LrhA to this fragment (Fig. 3B) . In contrast, for leuO fragments "I," "II," "III" and "V" two distinct bands were visible even at the highest LrhA His6 (1 mM) concentrations suggesting that LrhA does not specifically bind to these fragments (Fig. 3B) . In a second set of EMSA, tiling 90 bp fragments "1" to "9" (with fragments shifted to each other by 20 bp) were incubated with increasing concentration of LrhA His6 , in parallel to a 90 bp lacZ control fragment (Fig. 3C ). Here binding to fragment "5" was most efficient. In addition, fragments "4," "6" and "7" were retarded, while the other fragments were bound only at highest LrhA His6 concentration or not at all (Fig. 3C ). Taken together, the data suggest that the LrhA DNA-binding site partially overlaps with the LeuO-I DNA-binding site and the AT-rich presumptive H-NS nucleation site (sequence shown in Fig. 4 ).
LrhA activates three leuO promoters
To map leuO promoters that are activated by LrhA we performed 5 0 RACE of RNA specific for the P leuO lacZ reporter present in DlrhA DleuO D(yjjQ-bglJ) strain T2026. This isogenic triple deletion strain was used to avoid possible interference with chromosomal encoded LrhA, LeuO or BglJ. Previously it was shown that transcription under de-repressed conditions in Dhns and hns stpA mutants starts predominantly at promoter leuOp1, whereas BglJ-RcsB activates promoter leuOp2 (Fig. 4) . In presence of LrhA three transcription start sites were mapped including leuOp1, and two additional transcription start sites (sequence shown in Fig. 4 , gel of the 5 0 RACE products is shown in Fig.  5) . One of the LrhA activated promoters maps 33 bp downstream of leuOp1 and presumably corresponds to transcription start leuOp mapped previously one base pair downstream of the site mapped here (Chen et al., 2005) . The transcription start site of LrhA activated leuOp3 maps 4 and 6 bp upstream of leuOp2 (Fig. 4) . For comparison, the 5 0 RACE analysis was repeated in ) and presence of plasmidic lrhA (pKEHB7) (1LrhA), ydcI (pKEHB6) (1YdcI), cynR (pKETS23) (1CynR) and bglJ (pKETS1) (1BglJ), respectively, in strain T32. Cultures for b-galactosidase assays were grown to OD 600 of 0.5 in LB medium supplemented with 1 mM IPTG and kanamycin. Mean values of at least 3 replicates are shown as bars, and error bars indicate standard deviations. The 1BglJ value is taken from .
(B) Chromosomal leuO expression was determined by qRT-PCR using RNA that was isolated from lrhA 1 strain U3 (2) and DlrhA strain U79 (2). In addition transformants of U79 harboring lrhA expression vector pKEHB7 (1LrhA), bglJ expression vector pKETS1 (1BglJ) or empty vector pKESK22 (ctrl) were analyzed. qPCR of the cDNA was performed with leuO specific primers T351 and T352, and Ct values were normalized to rpoD expression determined with primers T247 and T248. The relative expression level of leuO in presence of BglJ was defined as 100 arbitrary units.
presence of BglJ, which confirmed activation of leuOp2 by BglJ-RcsB (Fig. 5 ).
Co-regulation of leuO transcription by LrhA, LeuO and BglJ-RcsB
To further characterize the role of LrhA in regulation of leuO transcription we analyzed the interplay of LrhA with BglJ-RcsB and LeuO respectively. To this end, we determined expression levels of the P leuO lacZ reporter and mapped 5 0 ends of transcripts by RACE in presence of LrhA and LeuO as well as in presence of LrhA and BglJ-RcsB both in the wild-type and in the hns stpA mutant (Fig. 5 ). First, we analyzed co-regulation by LrhA and BglJ-RcsB. LrhA was provided from plasmid pKEHB7 and BglJ was constitutively expressed from chromosomal allele bglJ c . As shown above LrhA activates P leuO lacZ expression approximately 12-fold (compare 4 and 48 units, Fig. 5 ), while BglJ (encoded by chromosomal allele bglJ c ) activates P leuO lacZ approximately 50-fold (Fig. 5 ). Upon co-expression of LrhA with BglJ, P leuO lacZ expression increased from 195 to 269 units (the statistical significance according to student's t-test is P < 0.05). The 5 0 RACE data confirm activation of the leuOp2 promoter by BglJ-RcsB ( Fig. 5 ) and suggest that LrhA does not inhibit this activation (Fig. 5) . However, when BglJ and LrhA were both present only 5 0 RACE products corresponding to a transcription start at the BglJ-RcsB activated p2 promoter could be detected by sequencing, which may reflect that activation by BglJ is very strong in comparison to activation of p3 by LrhA.
Second, we co-expressed LeuO and LrhA. Again, LrhA was provided from plasmid pKEHB7, while LeuO was provided by constitutive chromosomal allele leuO c . The data reveal that LeuO reduced activation by LrhA from 48 units to 24 units (Fig. 5) . Similarly, in the 5 0 RACE analysis the intensity of the bands decreased in presence of LeuO (Fig. 5) indicating that LeuO interferes with activation by Fig. 3 . Binding of LrhA to the leuO promoter region. (A) Schematic of the leuO promoter region. Fragments "I" to "V" and "1" to "9" used for electrophoretic mobility shift assays are depicted as solid lines and were amplified by PCR using oligonucleotides listed in Table 3 . LeuO-I and LeuO-II indicate the DNA-binding sites of LeuO, and BglJ-RcsB indicates the DNA-binding site of the heterodimeric BglJ-RcsB . (B) Electrophoretic mobility shift assays of DNA fragments "I" to "V" by LrhA. A 262 bp lacZ fragment that was amplified by PCR with primers S9 and S127 was used as control (open arrowhead). Mixtures of the DNA fragments "I" to "V" with the lacZ control fragment were incubated with indicated concentrations of purified LrhA His6 . (C) Electrophoretic mobility shift assays of 90 bp DNA fragments "1" to "9" and a 90 bp lacZ control fragment by LrhA. LrhA His6 concentrations are indicated. The samples were separated on 8% native polyacrylamide gels, and the gels were stained with ethidium bromide. Gel pictures are shown with inverted colors.
LrhA. Sequencing of the 5 0 RACE products confirmed repression of leuOp1 by LeuO.
Third, transcription regulation and transcripts of leuO were analyzed in Dhns stpA mutants. The expression data confirm derepression of the P leuO lacZ reporter in the hns stpA mutant (Stratmann et al., 2012) (252 units, Fig. 5) . In presence of LeuO and LrhA, respectively, expression was reduced to 129 and 141 units respectively (Fig. 5) . Intriguingly, LeuO and LrhA together strongly repress P leuO lacZ expression (25 units, Fig. 5 ). These results are supported by the 5 0 RACE data, which revealed a decrease in the intensity of the band representing p1 and p, and also of the p2/p3 specific band in presence of LrhA and LeuO (Fig. 5) . Taken together the data indicate that LeuO and LrhA synergistically reduce transcription initiation by RNA polymerase in the hns stpA mutant.
Screen for hyperactive LrhA mutants
LrhA is a LysR-type regulator. The activity of some of these regulators is modulated by a co-effector, and for some LysR regulators constitutively active mutants have been identified (Momany and Neidle, 2012) . For LrhA no co-effector is known. Here we performed a screen for mutants of LrhA with increased activity. To this end, lrhA gene fragments were amplified by PCR using the nonproofreading Taq polymerase and cloned into the lacI q P tac expression plasmid pKESK22. Transformants of the P leuO lacZ reporter strain T308 (DleuO DbglJ) were screened on tryptone X-Gal indicator plates for a Lac 1 phenotype. Of 72 mutagenesis PCRs this screen yielded 6 independent weakly Lac 1 clones representing 4 different LrhA mutants (Fig. 6 ). These mutants include 2 independent isolates of LrhA-12DN, 2 independent isolates of LrhA-303DG, and 1 isolate each of LrhA-221TA and LrhA-61HR/221TA. For further analyses, transformants of the P leuO lacZ DlrhA strain T2026 with the plasmids containing the lrhA mutants were spotted in serial dilutions on X-Gal indicator plates without and with IPTG (Fig. 6 ). Transformants LeuO and H-NS/StpA. Expression of the P leuO lacZ reporter was determined in absence (2) and presence (1) of LrhA. Bars indicate mean values and standard deviations. For co-expression of bglJ and leuO strains carrying the constitutive alleles leuO c and bglJ c were used. Exponential cultures were assayed. In parallel, RNA was analyzed by 5 0 RACE using P leuO lacZ specific primer T41. All 5 0 RACE samples were separated on the same gel and sections of the gel picture are shown in inverted color below the genotype of the strain. Analyzed were transformants of strains T2026 (DleuO DbglJ DlrhA), T2030 (leuO C DbglJ DlrhA), T2027 (DleuO DbglJ DlrhA hns stpA), T2031 (leuO C DbglJ DlrhA hns stpA) and T2028 (DleuO bglJ C DlrhA) with plasmids pKESK22 and pKEHB7. Fig. 4 . Sequence of the leuO regulatory region and LrhA-activated promoters. Promoters leuOp1, leuOp and leuOp2 were described (Chen et al., 2005; Stratmann et al., 2012) . Promoters p1, p and p3 are activated by LrhA. For leuOp the transcription start site mapped by 5 0 RACE is shown in bold, and the transcription start site mapped previously (Chen et al., 2005) is underlined. The 90 bp fragment "5," which was bound best by LrhA (Fig. 3) , is marked by a dotted line. LeuO DNA-binding sites LeuO-I and LeuO-II and the BglJ-RcsB DNA-binding site are underlined. The presumptive H-NS nucleation sites (Chen et al., 2005 ) is indicated by a box.
harboring LrhA-303DG (pKEHB37) were weakly Lac 1 on plates without IPTG, while the phenotype conferred by the other mutants was indistinguishable from wildtype LrhA and the empty vector control (Fig. 6 ). On indicator plates with IPTG all transformants of plasmids providing wild-type or mutant LrhA were Lac 1 . Interestingly, mutants LrhA-12DN, LrhA-221TA and LrhA-61HR/221TA conferred a growth defect (possibly this phenotype distinguished these mutants in the screen) (Fig. 6) . Due to the growth defect conferred by the LrhA mutants a quantitative assay of P leuO activation was not feasible. Furthermore, DNA binding by the LrhA mutants was analyzed by EMSA using leuO DNA fragment "IV," which is specifically bound by LrhA (Fig. 3) . Purified mutant proteins LrhA His6 -303DG, 221TA and 61HR/221TA, respectively, bound fragment "IV" at similar concentrations of 250 nM as wild-type LrhA (Fig. 7A) . In contrast, LrhA-12DN His6 bound as of a concentration of 50 nM. In addition, LrhA-12DN His6 bound to the unspecific lacZ control fragment at a concentration of 250 nM indicative of an enhanced DNA-binding affinity. To envisage how mutation 12DN may affect DNA binding a structural model of the DNA-binding domain of LrhA (residues 1 to 96) was computed using Swissmodel (swissmodel.expasy.org) (Biasini et al., 2014) . The overlay of the structural models that are based on the three templates of highest homology (including 3isp.1.B, ArgP from Mycobacterium tuberculosis, 3k1n.1.B BenM from Acinetobacter baylyi, and 5fo5.1.A, MetR from E. coli) indicates that residue 12D is located at the beginning of helix 1 of the wHTH DNA-binding domain in which helix 3 constitutes the DNA recognition helix (Aravind et al., 2005) (Fig. 7B ). According to this structural model residue 12D of LrhA presumably corresponds to arginine 4 of BenM of A. baylyi which interacts with the DNA backbone (Alanazi et al., 2013) . Thus, one may speculate that mutation of LrhA at negatively charged glutamic acid residue 12 to the neutral and polar asparagine may enhance DNA binding.
The other LrhA mutations were also mapped to structural models. Residue 61HR maps to the wing of the wHTH domain, and may correspond to residue 53R in BenM which also interacts with the DNA backbone (Fig.  7B) . For residues 221T a model that is built on the structure of the RovM effector binding domain (3onmA) (Quade et al., 2011) , which is the LrhA homologue from Vibrio pseudotuberculosis and 59% identical with E. coli LrhA, is available at ModBase (Pieper et al., 2014) (http://modbase.compbio.ucsf.edu/). According to this model, residue 221TA maps to the dimerization interface and in vicinity to the presumptive effector binding cleft of LrhA (Fig. 7C) . Residue 303DG is not represented in the model of the LrhA effector binding domain. However, in case of the LysR-type regulator LeuO of S. enterica the C-terminal residues affect transcription activation by LeuO (Guadarrama et al., 2014) .
Taken together, the data indicate that LrhA-12DN has an increased DNA-binding affinity, whereas DNA binding by the mutants LrhA-303DG, LrhA-221TA and LrhA-61HR/221TA is not affected. The enhanced activation and growth effects caused by these mutants may be based on structural alteration of the effector binding domain that influence LrhA activity.
Discussion
Here we have shown that LrhA activates transcription of leuO in E. coli. LrhA binds the leuO promoter region and activates promoters leuOp1, leuOp, and a newly identified leuOp3. The negative autoregulator LeuO reduces activation by LrhA, while activation of leuO by LrhA and the positive regulator BglJ-RcsB is synergistic. Further, LrhA mutants (12DN, 221TA, 61HR/221TA and 303DG) were identified in a screen and plasmidic induction of mutants LrhA-12DN, LrhA-221TA (LrhA-61HR/ 221TA) was deleterious to bacterial growth suggesting that these mutants are hyperactive. Regulation of leuO by LrhA implies a connection of LeuO and LrhA, which are both LysR-type transcription regulators of pleiotropic function.
In a genomic library screen we identified LrhA as transcription activator of leuO (Fig. 1) . LrhA activates leuO transcription approximately 12-fold (Fig. 2) . In addition to LrhA, clones carrying bglJ, cynR and ydcI were isolated. BglJ-RcsB strongly activates the leuOp2 promoter , while activation of leuO transcription by CynR and YdcI was moderate (Fig. 2) and not further analyzed. Recently SlyA, a MarA family harboring plasmids carrying lrhA and mutants (pKEHB7, pKEHB33, pKEHB37, pKEHB38, pKEHB39) was analyzed. Overnight cultures grown in LB kanamycin medium were diluted to an OD 600 of 1, which equals about 10 9 cells per ml. Then 10 ml (5 10 22 ml) and 10 ml of 10-fold serial dilutions (10
23
, 10
24 , 10 25 , 10
26
, 10 27 ) were spotted on tryptone X-Gal kanamycin plates without (-IPTG) and with 200 mM IPTG (1IPTG). Strain T2026 (DlrhA) harboring vector pKESK22 was used as control.
LrhA activates leuO 669 transcription regulator, has been characterized as activator of leuO (Curran et al., 2017) , but this regulator was not identified in our screen.
Characterization of leuO regulation by LrhA by DNAbinding analysis and mapping of transcripts suggests that LrhA activates several promoters. The activated promoters, leuOp1 and leuOp, map approximately 110 to 140 bp downstream of the center of the LrhA binding region, while promoter leuOp3 maps approximately 250 bp downstream of the LrhA binding region and close to the BglJ/RcsB activated leuOp2 promoter. LrhAmediated activation of leuO transcription might be mediated directly by recruitment of RNA polymerase. However, it is feasible that activation of transcription by LrhA is mediated indirectly by disturbing formation of a repressive nucleoprotein-complex by H-NS and StpA. This could allow RNA polymerase to bind various promoter elements in the particularly AT-rich (> 70% AT) leuO regulatory region, and also stimulate activation of leuOp2 by BglJ-RcsB (Fig. 8) . Co-regulation of leuO by LrhA and LeuO is more complex. In the wild-type LeuO reduces activation by LrhA in accordance with overlapping DNA-binding sites and LeuO functioning as autorepressor. However, in hns stpA mutants, that is, when leuO transcription is not repressed, LeuO and LrhA synergistically inhibit transcription. LeuO and LrhA are both LysR-type transcription regulators which in general favor AT-rich DNA and bind DNA of the degenerate T-N 11 -A DNA sequence (Parsek et al., 1994; Maddocks and Oyston, 2008) . Possibly, in presence of both regulators their occupancy of low affinity sites may synergistically inhibit RNA polymerase binding. A similar observation was made for the H-NS repressed hlyE, which is derepressed by SlyA in the wild-type, but SlyA has a small negative effect in the absence of H-NS (Lithgow et al., 2007) . In addition, it should be considered that LeuO, although generally an H-NS antagonist, also functions as a repressor not just in autoregulation, but also of other loci. For example, in case of the S. enterica pathogenicity island SPI-1, LeuO represses SPI-1 under conditions that impair repression by H-NS and thus may function as H-NS back-up (Espinosa and Casades us, 2014) . Furthermore, DNA supercoiling as well as DNA topology and curvature may play a role in regulation of leuO. DNA curvature has been shown to be important for regulation of S. enterica ompS1 by LeuO and H-NS (De la Cruz et al., 2009).
The LrhA DNA-binding site was mapped by EMSA (Fig. 3) to a region which overlaps the H-NS nucleation site and one of the LeuO DNA-binding sites (Chen et al., 2005; Stratmann et al., 2012) . In the EMSA, tiling 90 bp fragments were used and the fragment that centers 110 bp upstream of leuOp1 was bound by LrhA with highest affinity. Intriguingly, fragments that are 20 or DNA-binding by LrhA mutants 12DN, 221TA, 61HR/221TA and 303DG was tested by electrophoretic mobility shift assays. Mixtures of fragment "IV" (specifically bound by wild-type LrhA, Fig. 3 ) and lacZ control fragment (ctrl) were incubated with the indicated concentration of LrhA His6 -12DN, 221TA, 61HR/221TA and 303DG proteins. Samples were separated on native 8% acrylamide gels, and the gels were stained with ethidium bromide. (B) Structural model of the N-terminal wHTH DNA-binding domain (amino acid residues 11-93) of LrhA. Shown is an overlay of the three structure predictions calculated on basis of the templates showing the highest protein similarity (3isp.1.B, 3k1n.1.B and 5fo5.1.A). Amino acid residues 12 and 61 are shown in red. Protein similarity was calculated by swissmodel (swissmodel.expasy.org). (C) Structural model of the C-terminal effector-binding domain of LrhA based on the structure of the Y. pseudotuberculosis LrhA homologue RovM (3onmA), which is 59% identical to E. coli LrhA. Model available at Modbase (Pieper et al., 2014). 40 bp shifted were bound by LrhA, as well, while no binding was detected for a set of 70 bp tiling fragments (not shown). These results indicate that DNA contacts by LrhA are rather extended. In general, LysR-type transcription regulators generate extended footprints, for example up to 70 bp in case of LeuO . Assuming that LrhA is similar to other LysR-type transcription regulators, two dimers of the wHTH DNAbinding domains are present in the presumptive LrhA tetramer, which may contact rather distant DNA sites, as described for DntR and other LysR-type regulators (Lerche et al., 2016) .
LrhA in E.coli and its homologues in other enterobacterial species named LrhA, HexA, PecT and RovM, respectively, are of presumably pleiotropic function, which includes repression of virulence and control of lifestyle switches (see introduction). In E. coli translation profiling suggests synthesis of LrhA at a significant level (Li et al., 2014) . However, up to date little is known about regulation of lrhA gene expression and LrhA protein function. We isolated mutants LrhA-12DN, LrhA-221TA, double mutant 61HR/221TA and LrhA-303DG in a screen for LrhA variants of increased activity. Structural models of the N-terminal LrhA wHTH DNA-binding domain indicates that residue 12D corresponds to residue 4R in BenM (Alanazi et al., 2013) and thus may interact with the DNA minor groove and DNA backbone. Therefore, a change from the negatively charged amino acid aspartic acid to the polar asparagine may facilitate DNA binding, as observed. Residue 61H presumably corresponds with residue 53R of BenM that also interacts with the DNA backbone (Alanazi et al., 2013) . A structural model of the C-terminal effector binding domain of LrhA, which is based on the Y. pseudotuberculosis homologue RovM (59% identity), indicates that residue 221T maps to the dimerization surface of the effector binding domain and next to the presumptive effector binding cleft. The C-terminal LrhA residue 303D is not represented in the structural model. However, the C-terminal residues of LeuO of S. enterica are important for oligomerization (Guadarrama et al., 2014) . Mutations 221TA and possibly 303DG may strengthen dimerization and oligomerization of LrhA or induce a structural change that enhances LrhA activity. Activity of LrhA might be controlled by co-effector binding to the Cterminal domain or by environmental stress signals that affect the configuration of LrhA, as known for other LysR-type transcription regulators (Ruangprasert et al., 2010; Momany and Neidle, 2012; Taylor et al., 2012; Lerche et al., 2016) . For example, in case of CynR, ArgP, and BenM binding of an effector does not increase DNA-binding affinity, but induces a transition from the apo-to the holo-configuration and a concomitant change of the distance of these two DNA-contact sites described as the model of a sliding dimer mechanism (Lamblin and Fuchs, 1994; Ezezika et al., 2007; Laishram and Gowrishankar, 2007; Lerche et al., 2016) . In contrast, crystal structures of AphB and its constitutive mutant N100E suggests that the constitutive mutant adopts a more open conformation that may favor DNA binding, while in the symmetric structure of wild-type protein a steric clash may hinder DNA binding (Taylor et al., 2012) .
LrhA is an additional regulator of leuO that adds to the complex regulation of leuO transcription. LrhA might be a factor that couples leuO expression to a yet to be defined signal input. Intriguingly, mutants LrhA-12DN and 221TA cause a growth defect, which is in agreement with their identification as hyperactive mutants and in support of a pleiotropic function of LrhA in E. coli.
Experimental procedures
Strains, plasmids and bacteria cultivation E. coli K12 strains were constructed by Red-Gam-mediated gene deletion (Datsenko and Wanner, 2000) and T4GT7 mediated general transduction (Wilson et al., 1979) , respectively, and all strains are listed in Table 1 . Construction of plasmids, which are listed in Table 2 , and other molecular techniques were performed according to published protocols (Ausubel et al., 2005) . Oligonucleotides are listed in Table 3 . E. coli cultures were grown in LB (10 g/l Bacto Tryptone, 5 g/l Bacto Yeast Extract, 5 g/l NaCl) or Tryptone medium (10 g/l Bacto tryptone, 5 g/l NaCl). For plates 15 g/l Bacto Agar was added. Antibiotics were used in final concentrations of 50 lg/ml ampicillin, 15 lg/ml chloramphenicol and 15 lg/ml kanamycin, where indicated. IPTG (isopropyl-b,Dthiogalactopyranoside) was added for induction at a concentration of 1 mM in liquid cultures and 200 mM in plates, where indicated. X-Gal (5-bromo-4-chloro-3-indolyl-b-Dgalactopyranoside) was added at a final concentration of 40 mg/ml to plates for screening of Lac phenotypes. 
Expression analyses
For b-galactosidase assays cultures were inoculated to OD 600 of 0.05 and grown to OD 600 of 0.5 in LB medium that was supplemented with kanamycin, when required and with 1 mM IPTG, where indicated. The bgalactosidase enzyme assays were performed as described (Miller, 1992) and average values were calculated from at least three biological replicates. Quantitative reverse transcriptase PCR (qRT-PCR) was performed as described Salscheider et al., 2014) . Briefly, RNA was isolated from cultures grown in LB medium to the exponential phase (OD 600 0.5) using the bacterial RNAprotect and RNeasy MiniKit system (Qiagen, Germany). Then cDNA was synthesized with the SuperScript III First Strand Synthesis Kit (Invitrogen, Germany) using 1 mg of RNA and random hexameric oligonucleotides as primers. Subsequently, quantitative PCR was carried out with gene specific oligonucleotide (Table 3) , SYBR Green I and a C1000 touch thermal cycler with optical reaction module CFX96 (Bio-Rad). For each reaction 2 ml of 1:10 diluted cDNA and 4 ll dNTPs (1 mM each), 4 ll 53 buffer, 6.8 ll DEPC-treated H 2 O, 0.8 ll DMSO, 0.2 ll SYBR green (1:1000 in DMSO), 0.2 ll GoTaq DNA Polymerase (Promega) and 1 ll of each primer (10 pmol/ll) were used. Data were normalized to rpoD as reference gene using an efficiency-corrected, normalized expression (DDCt) algorithm.
Genomic library screen
To screen for activators of leuO transcription we used a plasmid-based genomic library that carries 1.5-5 kb genomic fragments generated by partial Sau3AI digestion cloned in pKESK22 (p15A-ori, kanamycin resistance) downstream of lacI q P tac cassette (Stratmann, 2012) . To screen for transactivating factors strain T28 harboring chromosomal P leuO lacZ reporter was transformed with the library by electroporation. Transformants were selected on tryptone plates supplemented with X-gal, kanamycin, and 200 mM IPTG. Lac 1 clones were re-streaked, analyzed by PCR using plasmid specific primers, followed by sequencing of the genomic fragment. The sequencing data showed that the clones represent seven different loci. Re-transformation of representative clones and of sub-clones using plasmids pKETS1 (bglJ), pKETS23 (cynR), pKEHB06 (ydcI), pKEHB07 (lrhA) confirmed activation of the P leuO lacZ reporter.
Mapping of transcription start sites
To map leuO transcription start sites 5 0 RACE (rapid amplification of cDNA ends) was performed, as described a. Gene designations are aadA coding for spectinomycin resistance, cm for chloramphenicol resistance, tet for tetracyclin resistance, att-B::(aadA P leuO lacZ) for a fusion of the 892 bp leuO regulatory region to lacZ (encompassing the leu-leuO intergenic region from 2847 to 145 relative to the leuO translation start). The P leuO lacZ fusion is integrated at the phage Lambda attachment-site attB . FRT is the Flp recombinase target site. b. Construction of strains was performed by transduction using phage T4GT7 which is indicated by "x T4GT7 (donor strain or allele)" and by Red-Gam mediated site-specific recombination with the oligonucleotides and template used for generating of the PCR fragments indicated by "x PCR OA65/OA66." Resistance cassettes flanked by FRT-sites were deleted using temperature-sensitive plasmid pCP20, as described (Datsenko and Wanner, 2000) . All constructed and transferred alleles were confirmed by PCR. For transduction of allele leuO-Y1::miniTn10-cm (5leuO c , cm) strain S1729 and for transduction of yjjQ/bglJ-Y6::miniTn10-cm (5bglJ c , cm) strain S1734 was used as donor strain (Madhusudan et al., 2005) . (Wagner and Vogel, 2005) . RNA of bacterial cultures was isolated as described above. To distinguish between primary and processed 5 0 ends 6 mg RNA were treated with 10 units of RNA 5 0 -pyrophosphohydrolase RppH (New England Bioloabs, USA), which removes the 5 0 triphosphate of primary transcripts, while another 6 mg of RNA was left untreated. Then the RNA adapter T268 was ligated using RNA ligase, followed by phenol:chloroform:isoamylalcohol (25:24:1) extraction and ethanol precipitation. After resuspension in 20 ml H 2 O half of the RNA sample was used for cDNA synthesizis with the SuperScript III First Strand Synthesis Kit (Invitrogen, Germany) using random hexameric oligonucleotides as primers. The cDNA was amplified with PlatinumTaq Polymerase (Invitrogen, Germany) including RNA adapter specific DNA primer T265 and a genespecific DNA primer (Table 3) . PCR products were analyzed on 2% agarose gels. For sequencing the PCR products were digested with EcoRI and XbaI, gel purified, and ligated into pUC12. After transformation of these ligations at least 6 clones were sequenced for each RACE fragment.
Purification of LrhA and LrhA mutants
Purification of C-terminally histidine-tagged LrhA (LrhA His6 ) and LrhA mutants LrhA-12DN His6 (pKEHB41), LrhA-303DG His6 (pKEHB42), LrhA-221TA His6 (pKEHB44) and LrhA-61HR/221TA His6 (pKEHB43) was performed in expression strain C41(DE3). For purification of each protein four one-liter cultures of LB medium with ampicillin were inoculated from a fresh overnight culture to an OD 600 of 0.1 and grown to OD 600 of 0.6, at which point IPTG was added to a final concentration of 200 mM, and cultures were grown for additional 5 h at 28˚C. The cultures were harvested on ice, the cells were pelleted by centrifugation, resuspended in resuspension buffer (20 mM Tris-HCl pH 8.0, 300 mM NaCl), and pelleted again. Cell pellets were stored at 280˚C. For lysate preparation, the pellets were resuspended at 4˚C in lysis buffer [4 ml/ g of cells; 20 mM Tris-HCl pH 8.0, 300 mM NaCl, 20 mg/ml DNaseI (5000 U/ml; New England Biolabs, USA)]. Cell lysates were generated by French press, adjusted to 10 mM imidazole, and cleared by centrifugation (50,000g, 4˚C, 45 min). The cleared lysate supernatant was loaded onto 1 ml HisTrap HP column (GE Healthcare, Germany) equilibrated with the same buffer using an € AKTA FPLC (fast protein liquid chromatography system, GE Healthcare, Germany). The column was washed with buffers of increasing imidazole concentrations (10, 30 and 50 mM). The proteins were eluted with the same buffer with 250 mM imidazole, and fractions were analyzed by SDS-PAGE. The LrhA protein containing fractions were pooled, the buffer was exchanged to 20 mM Tris (pH 8.0), 300 mM NaCl and 1 mM DTT using PD-10 desalting columns (GE Healthcare), and the proteins were stored at 280˚C.
Electrophoretic mobility shift assay (EMSA)
DNA fragments used for EMSA were amplified by PCR using the oligonucleotide primers (Table 3) . Binding of LrhA His6 and LrhA mutants was carried out in 10 ml binding buffer (20 mM Tris-HCl pH 7.5, 100 mM KCl, 2 mM DTT and 10% glycerol), ontaining 20 ng of each DNA fragment lrhA-303DG His6 in pET-22b bla lrhA-303DG PCR fragment of pKEHB37, cloned as pKEHB40 pKEHB43
lrhA-61HR/221TA His6 in pET-22b bla lrhA-61HR/221TA PCR fragment of pKEHB38, cloned as pKEHB40 pKEHB44
lrhA-221TA His6 in pET-22b bla lrhA-221TA PCR fragment of pKEHB39, cloned as pKEHB40 a. Vector features include bla conferring ampicillin resistance, pSC101-rep ts for temperature sensitive replication origin of pSC101, aadA conferring spectinomycin resistance, neo for kanamycin resistance. For LrhA mutants the sequence of the wild-type and mutant codon is given in brackets. b. PCR fragments were amplified with the indicated oligonucleotides, digested with restriction enzymes, gel purified and cloned. Cloning of all fragments was verified by sequencing.
and LrhA protein, as indicated. Samples were incubated at 30˚C for 20 minutes and then loaded on an 8% native polyacrylamide gel (acrylamide:bisacrylamide 29:1; 0.53 TBE) that was run at 4˚C. For visualization, the gels were stained with ethidium bromide. 
